GlassScriptPhysician profile
David Neil Gunther
NPI 1154359347
$9,515.39
in general payments reported to CMS, 2019-2025
29 companies · $891 in 2025
The $891 reported for 2025 was more than what 78% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,042 · 2020: $832 · 2021: $661 · 2022: $1,455 · 2023: $922 · 2024: $711 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,287.02 | 2019-2025 | Flexband, Augment Injectable, Variax |
| Smith+Nephew, INC. | $370.20 | 2019-2025 | Renasys Touch, Stravix, Grafix Pl |
| Cpm Medical Consultants, LLC | $233.05 | 2023 | Orbitum Staple System |
| Horizon Therapeutics Plc | $192.55 | 2022 | |
| Osiris Therapeutics INC. | $150.18 | 2019 | |
| Encore Medical, LP | $142.82 | 2021 | |
| Treace Medical Concepts, INC. | $141.80 | 2024-2025 | |
| Acumed LLC | $103.34 | 2022 | |
| Imbed Biosciences INC. | $98.49 | 2022 | |
| Trilliant Surgical LLC. | $97.28 | 2020 | |
| Arthrosurface Incorporated | $93.88 | 2020 | |
| Mimedx Group, INC. | $65.78 | 2024 | |
| Paratek Pharmaceuticals, INC. | $58.25 | 2025 | Nuzyra |
| Amgen INC. | $52.71 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $42.85 | 2023-2024 | Venaseal |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $42.84 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $37.28 | 2024 | Vibativ |
| Kowa Pharmaceuticals America, INC. | $35.88 | 2022-2023 | Seglentis |
| Convatec INC. | $31.48 | 2023 | |
| Zyla Life Sciences, INC. | $31.12 | 2019 | |
| Kerecis Limited | $31.09 | 2022 | |
| Lifenet Health | $27.18 | 2025 | Theragenesis Wound Matrix |
| Grt US Holding, INC. | $26.89 | 2022 | |
| Abbott Laboratories | $23.59 | 2023 | Eterna |
| Paragon 28, INC. | $23.29 | 2023 | Gorilla |
| Fidia Pharma USA INC. | $21.05 | 2024 | |
| Ethicon US, LLC | $18.29 | 2020 | |
| Heron Therapeutics, INC. | $17.92 | 2023 | Zynrelef |
| Argentum Medical | $17.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gunther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.